Scilex Pharms Inc patents expiration
1. Ztlido patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10765640 | SCILEX PHARMS INC | Non-aqueous patch |
May, 2031
(7 years from now) | |
| US9931403 | SCILEX PHARMS INC | Non-aqueous patch |
May, 2031
(7 years from now) | |
| US10765749 | SCILEX PHARMS INC | Non-aqueous patch |
May, 2031
(7 years from now) | |
| US11278623 | SCILEX PHARMS INC | Non-aqueous patch |
May, 2031
(7 years from now) | |
| US9925264 | SCILEX PHARMS INC | Non-aqueous patch |
May, 2031
(7 years from now) | |
| US9283174 | SCILEX PHARMS INC | Non-aqueous patch |
May, 2031
(7 years from now) | |
Drugs and Companies using LIDOCAINE ingredient
Market Authorisation Date: 28 February, 2018
Treatment: Method for relieving the pain associated with post-herpetic neuralgia
Dosage: PATCH;TOPICAL
How can I launch a generic of ZTLIDO before it's drug patent expiration?
More Information on Dosage
ZTLIDO family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic